Skip to main content
TMS Co., Ltd logo

TMS Co., Ltd — Investor Relations & Filings

Ticker · 4891 ISIN · JP3544960002 T Manufacturing
Filings indexed 37 across all filing types
Latest filing 2026-03-30 Regulatory Filings
Country JP Japan
Listing T 4891

TMS Co., Ltd. is a clinical-stage company focused on the research, development, manufacture, and sale of drug products, quasi-drugs, and medical devices. Founded by scientists from the Tokyo University of Agriculture and Technology, the company aims to discover and develop transformative medicines for diseases with high unmet medical needs. Its research centers on a group of fungus-derived small molecule compounds known as SMTPs, which exhibit a novel dual mode of action. The company's objective is to create revolutionary drugs for conditions that currently lack effective treatments.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の4の2第1項' (Article 24-4-2, Paragraph 1 of the Financial Instruments and Exchange Act). It is a formal certification by the CEO and CFO confirming the accuracy of the contents of the Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a report, should be classified as Regulatory Filings (RNS). FY 2025
2026-03-30 Japanese
有価証券報告書-第22期(2025/03/01-2025/12/31)
Annual Report Classification · 100% confidence The document is a 'Yuka Shoken Hokokusho' (Annual Securities Report) filed with the Kanto Local Finance Bureau in Japan. It contains comprehensive financial statements, management discussion, and corporate information for the fiscal year ending December 31, 2025. This is the Japanese equivalent of a 10-K filing. FY 2025
2026-03-30 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under Article 24-5-2 of the Financial Instruments and Exchange Act of Japan, which accompanies a semi-annual report (第2四半期報告書). Since this document is a formal regulatory filing required to accompany the interim report to confirm the accuracy of the financial statements, and it does not contain the full financial report itself, it falls under the category of Regulatory Filings.
2025-10-15 Japanese
半期報告書-第22期(2025/03/01-2025/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) for the company '株式会社ティムス' (TMS Co., Ltd.) covering the period from March 1, 2025, to August 31, 2025. It contains detailed financial statements, management analysis (MDA), and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). Q2 2025
2025-10-15 Japanese
臨時報告書
AGM Information Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and explicitly states in Section 1 that it is being filed because resolutions were passed at the company's 21st Annual General Meeting (定時株主総会) held on May 29, 2025, pursuant to the Financial Instruments and Exchange Act. The content details the resolutions passed, including changes to the articles of incorporation, capital reduction, and the election of directors and auditors. This document reports the official results of a shareholder vote following a general meeting. The most specific category for reporting official results from shareholder votes at a general meeting is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it relates to the AGM, the core content is the voting outcome report, not the AGM presentation materials (AGM-R).
2025-05-30 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document text contains Japanese characters and clearly references "有価証券報告書" (Yuka Shoken Hokokusho), which translates to 'Securities Report' or 'Annual Securities Report'. It also specifies the filing date (2025年5月30日), the filing destination (関東財務局長 - Director of the Kanto Local Finance Bureau), and confirms the accuracy of the report for the fiscal period ending February 28, 2025. In the context of US SEC filings, the comprehensive annual report is the 10-K. While this is a Japanese filing, the content—a confirmation of the accuracy of the annual securities report—is functionally equivalent to the certification required for a 10-K filing, which covers the full year's performance. Given the options, the closest equivalent for a comprehensive annual report is '10-K'. The document itself is a confirmation/certification related to the annual report, but since it deals with the full annual filing content, 10-K is the most appropriate classification among the choices provided, as it is not merely an announcement of publication (RPA/RNS) but a core component/certification of the annual filing itself. FY 2025
2025-05-30 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.